# Co-Exposure to Bisphenol A and a High-Fat Diet Induces Insulin Resistance via Suppression of Insulin Signaling Molecule Expression and GLUT4 Translocation

**Authors:** Zeqi Lu, Min Cao, Jiaoxiang Zhang, Congzheng Qi, Bing Huang, Wenxue Li, Juntao Li, Guangyu Yang, Yan Zhang, Jinyin Wu, Weiwen Liu, Wei Zhu

PMC · DOI: 10.3390/toxics14020146 · Toxics · 2026-02-01

## TL;DR

This study shows that combining bisphenol A exposure with a high-fat diet worsens insulin resistance by disrupting insulin signaling and GLUT4 translocation in muscle cells.

## Contribution

The study reveals novel mechanisms by which co-exposure to BPA and a high-fat diet impairs insulin signaling and GLUT4 translocation.

## Key findings

- Co-exposure to BPA and a high-fat diet reduces insulin signaling molecule expression in mouse muscle.
- BPA and palmitic acid inhibit GLUT4 translocation in C2C12 myotubes, contributing to insulin resistance.
- Combined exposure significantly alters insulin signaling pathways in both in vivo and in vitro models.

## Abstract

While the adverse health effects of bisphenol A (BPA) or high-fat diet (HFD) exposure alone have been relatively well documented, the mechanisms underlying their combined impact on insulin resistance and type 2 diabetes remain poorly understood. In this study, we observed the effects of 90 days of treatment with BPA and an HFD on insulin resistance in mouse gastrocnemius muscle, as well as the expression of signaling molecules and proteins potentially associated with glucose transporter type 4 (GLUT4) translocation. Additionally, C2C12 myotubes were co-treated with BPA and palmitic acid (PA) to observe the effects on insulin signaling molecules, GLUT4 translocation, and insulin resistance. Specifically, in vitro cellular experiments further demonstrated that BPA and PA inhibited GLUT4 translocation from the nucleus to the cell membrane. Taken together, co-exposure to BPA and an HFD (or PA) treatment significantly altered the expression of insulin signaling molecules in both gastrocnemius muscle and C2C12 cells, suggesting a potential link to their impacts on insulin resistance and GLUT4 translocation.

## Linked entities

- **Proteins:** SLC2A4 (solute carrier family 2 member 4)
- **Chemicals:** bisphenol A (PubChem CID 6623), palmitic acid (PubChem CID 985)
- **Diseases:** type 2 diabetes (MONDO:0005148)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Rab8a (RAB8A, member RAS oncogene family) [NCBI Gene 17274] {aka Mel}, Cort (cortistatin) [NCBI Gene 12854] {aka CST, PCST}, Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}, SLC2A4 (solute carrier family 2 member 4) [NCBI Gene 6517] {aka GLUT4}, Rab13 (RAB13, member RAS oncogene family) [NCBI Gene 68328] {aka 0610007N03Rik, B230212B15Rik}, Tbc1d4 (TBC1 domain family, member 4) [NCBI Gene 210789] {aka 5930406J04Rik, A930035N22, As160}, Stx4a (syntaxin 4A (placental)) [NCBI Gene 20909] {aka Stx4, Syn-4, Syn4}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 56637] {aka 7330414F15Rik, 8430431H08Rik, GSK-3, GSK-3beta, GSK3}, Slc2a4 (solute carrier family 2 (facilitated glucose transporter), member 4) [NCBI Gene 20528] {aka GT2, Glut-4, Glut4, twgy}, Vamp2 (vesicle-associated membrane protein 2) [NCBI Gene 22318] {aka Syb-2, Syb2, Vamp-2, sybII}, Glul (glutamate-ammonia ligase) [NCBI Gene 14645] {aka GS, Glns}, Snap23 (synaptosomal-associated protein 23) [NCBI Gene 20619] {aka 23kDa, SNAP-23, Sndt, Syndet}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Th (tyrosine hydroxylase) [NCBI Gene 21823]
- **Diseases:** T2DM (MESH:D003924), Dysfunction (MESH:D006331), glucose intolerance (MESH:D018149), cytotoxicity (MESH:D064420), IR (MESH:D007333), Obesity (MESH:D009765), metabolic disease (MESH:D008659), injury to (MESH:D014947), metabolic syndrome (MESH:D024821), Diabetes mellitus (MESH:D003920)
- **Chemicals:** CO2 (MESH:D002245), PA (MESH:D019308), paraformaldehyde (MESH:C003043), lipid (MESH:D008055), Glucose (MESH:D005947), DAPI (MESH:C007293), DMSO (MESH:D004121), FA (MESH:D005492), DMEM (-), 2-NBDG (MESH:C098340), lard (MESH:C029310), soybean oil (MESH:D013024), penicillin (MESH:D010406), corn oil (MESH:D003314), TM (MESH:D013932), epoxy (MESH:D004853), carbohydrate (MESH:D002241), CCK-8 (MESH:D012844), water (MESH:D014867), TL (MESH:D013793), glycogen (MESH:D006003), BPA (MESH:C006780), Blood glucose (MESH:D001786), Fat (MESH:D005223), sugars (MESH:D000073893), Triton X-100 (MESH:D017830), streptomycin (MESH:D013307), sodium pentobarbital (MESH:D010424)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C2C12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0188), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), CCK8 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_2873)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12944736/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12944736/full.md

## References

53 references — full list in the complete paper: https://tomesphere.com/paper/PMC12944736/full.md

---
Source: https://tomesphere.com/paper/PMC12944736